Impact of HemoDiaFIltration on Physical Activity and Self- Reported Outcomes (HDFIT)
Impact of HemoDiaFIltration on Physical Activity and Self-reported Outcomes: a Randomized Controlled Trial (HD-FIT Trial)
Sponsor: Fresenius AG
Listed as NCT02787161, this NA trial focuses on Chronic Kidney Disease and remains completed. Sponsored by Fresenius AG, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Oct 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Dec 2018 — Oct 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 3 earlier versions
-
Jun 2018 — Dec 2018 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
Phase: PHASE4 → NA
-
Jan 2017 — Oct 2017 [monthly]
Recruiting PHASE4
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fresenius AG
- Pontifícia Universidade Católica do Paraná
For direct contact, visit the study record on ClinicalTrials.gov .